United States Prenatal Screening Test Market Report 2016
- QYR715352
- 122 Pages
- October 2016
- Diagnostic and Biotech
Sales, means the sales volume of Prenatal Screening Test
Revenue, means the sales value of Prenatal Screening Test
This report studies sales (consumption) of Prenatal Screening Test in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Angle Plc (UK)
Hologic, Inc. (The US)
PerkinElmer, Inc. (The US)
Ravgen, Inc. (The US)
Sequenom, Inc. (The US)
Sequenom Center for Molecular Medicine, LLC (The US)
TrovaGene, Inc. (The US)
...
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Prenatal Screening Test in each application, can be divided into
Application 1
Application 2
Application 3
United States Prenatal Screening Test Market Report 2016
1 Prenatal Screening Test Overview
1.1 Product Overview and Scope of Prenatal Screening Test
1.2 Classification of Prenatal Screening Test
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Prenatal Screening Test
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Prenatal Screening Test (2011-2021)
1.4.1 United States Prenatal Screening Test Sales and Growth Rate (2011-2021)
1.4.2 United States Prenatal Screening Test Revenue and Growth Rate (2011-2021)
2 United States Prenatal Screening Test Competition by Manufacturers
2.1 United States Prenatal Screening Test Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Prenatal Screening Test Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Prenatal Screening Test Average Price by Manufactures (2015 and 2016)
2.4 Prenatal Screening Test Market Competitive Situation and Trends
2.4.1 Prenatal Screening Test Market Concentration Rate
2.4.2 Prenatal Screening Test Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Prenatal Screening Test Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Prenatal Screening Test Sales and Market Share by Type (2011-2016)
3.2 United States Prenatal Screening Test Revenue and Market Share by Type (2011-2016)
3.3 United States Prenatal Screening Test Price by Type (2011-2016)
3.4 United States Prenatal Screening Test Sales Growth Rate by Type (2011-2016)
4 United States Prenatal Screening Test Sales (Volume) by Application (2011-2016)
4.1 United States Prenatal Screening Test Sales and Market Share by Application (2011-2016)
4.2 United States Prenatal Screening Test Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Prenatal Screening Test Manufacturers Profiles/Analysis
5.1 Angle Plc (UK)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Prenatal Screening Test Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Angle Plc (UK) Prenatal Screening Test Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Hologic, Inc. (The US)
5.2.2 Prenatal Screening Test Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Hologic, Inc. (The US) Prenatal Screening Test Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 PerkinElmer, Inc. (The US)
5.3.2 Prenatal Screening Test Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 PerkinElmer, Inc. (The US) Prenatal Screening Test Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Ravgen, Inc. (The US)
5.4.2 Prenatal Screening Test Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Ravgen, Inc. (The US) Prenatal Screening Test Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sequenom, Inc. (The US)
5.5.2 Prenatal Screening Test Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sequenom, Inc. (The US) Prenatal Screening Test Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Sequenom Center for Molecular Medicine, LLC (The US)
5.6.2 Prenatal Screening Test Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Sequenom Center for Molecular Medicine, LLC (The US) Prenatal Screening Test Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 TrovaGene, Inc. (The US)
5.7.2 Prenatal Screening Test Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 TrovaGene, Inc. (The US) Prenatal Screening Test Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
...
6 Prenatal Screening Test Manufacturing Cost Analysis
6.1 Prenatal Screening Test Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Prenatal Screening Test
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Prenatal Screening Test Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Prenatal Screening Test Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Prenatal Screening Test Market Forecast (2016-2021)
10.1 United States Prenatal Screening Test Sales, Revenue Forecast (2016-2021)
10.2 United States Prenatal Screening Test Sales Forecast by Type (2016-2021)
10.3 United States Prenatal Screening Test Sales Forecast by Application (2016-2021)
10.4 Prenatal Screening Test Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
Figure Picture of Prenatal Screening Test
Table Classification of Prenatal Screening Test
Figure United States Sales Market Share of Prenatal Screening Test by Type in 2015
Table Application of Prenatal Screening Test
Figure United States Sales Market Share of Prenatal Screening Test by Application in 2015
Figure United States Prenatal Screening Test Sales and Growth Rate (2011-2021)
Figure United States Prenatal Screening Test Revenue and Growth Rate (2011-2021)
Table United States Prenatal Screening Test Sales of Key Manufacturers (2015 and 2016)
Table United States Prenatal Screening Test Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prenatal Screening Test Sales Share by Manufacturers
Figure 2016 Prenatal Screening Test Sales Share by Manufacturers
Table United States Prenatal Screening Test Revenue by Manufacturers (2015 and 2016)
Table United States Prenatal Screening Test Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Prenatal Screening Test Revenue Share by Manufacturers
Table 2016 United States Prenatal Screening Test Revenue Share by Manufacturers
Table United States Market Prenatal Screening Test Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Prenatal Screening Test Average Price of Key Manufacturers in 2015
Figure Prenatal Screening Test Market Share of Top 3 Manufacturers
Figure Prenatal Screening Test Market Share of Top 5 Manufacturers
Table United States Prenatal Screening Test Sales by Type (2011-2016)
Table United States Prenatal Screening Test Sales Share by Type (2011-2016)
Figure United States Prenatal Screening Test Sales Market Share by Type in 2015
Table United States Prenatal Screening Test Revenue and Market Share by Type (2011-2016)
Table United States Prenatal Screening Test Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Prenatal Screening Test by Type (2011-2016)
Table United States Prenatal Screening Test Price by Type (2011-2016)
Figure United States Prenatal Screening Test Sales Growth Rate by Type (2011-2016)
Table United States Prenatal Screening Test Sales by Application (2011-2016)
Table United States Prenatal Screening Test Sales Market Share by Application (2011-2016)
Figure United States Prenatal Screening Test Sales Market Share by Application in 2015
Table United States Prenatal Screening Test Sales Growth Rate by Application (2011-2016)
Figure United States Prenatal Screening Test Sales Growth Rate by Application (2011-2016)
Table Angle Plc (UK) Basic Information List
Table Angle Plc (UK) Prenatal Screening Test Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Angle Plc (UK) Prenatal Screening Test Sales Market Share (2011-2016)
Table Hologic, Inc. (The US) Basic Information List
Table Hologic, Inc. (The US) Prenatal Screening Test Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hologic, Inc. (The US) Prenatal Screening Test Sales Market Share (2011-2016)
Table PerkinElmer, Inc. (The US) Basic Information List
Table PerkinElmer, Inc. (The US) Prenatal Screening Test Sales, Revenue, Price and Gross Margin (2011-2016)
Table PerkinElmer, Inc. (The US) Prenatal Screening Test Sales Market Share (2011-2016)
Table Ravgen, Inc. (The US) Basic Information List
Table Ravgen, Inc. (The US) Prenatal Screening Test Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ravgen, Inc. (The US) Prenatal Screening Test Sales Market Share (2011-2016)
Table Sequenom, Inc. (The US) Basic Information List
Table Sequenom, Inc. (The US) Prenatal Screening Test Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sequenom, Inc. (The US) Prenatal Screening Test Sales Market Share (2011-2016)
Table Sequenom Center for Molecular Medicine, LLC (The US) Basic Information List
Table Sequenom Center for Molecular Medicine, LLC (The US) Prenatal Screening Test Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sequenom Center for Molecular Medicine, LLC (The US) Prenatal Screening Test Sales Market Share (2011-2016)
Table TrovaGene, Inc. (The US) Basic Information List
Table TrovaGene, Inc. (The US) Prenatal Screening Test Sales, Revenue, Price and Gross Margin (2011-2016)
Table TrovaGene, Inc. (The US) Prenatal Screening Test Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prenatal Screening Test
Figure Manufacturing Process Analysis of Prenatal Screening Test
Figure Prenatal Screening Test Industrial Chain Analysis
Table Raw Materials Sources of Prenatal Screening Test Major Manufacturers in 2015
Table Major Buyers of Prenatal Screening Test
Table Distributors/Traders List
Figure United States Prenatal Screening Test Production and Growth Rate Forecast (2016-2021)
Figure United States Prenatal Screening Test Revenue and Growth Rate Forecast (2016-2021)
Table United States Prenatal Screening Test Production Forecast by Type (2016-2021)
Table United States Prenatal Screening Test Consumption Forecast by Application (2016-2021)
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
